A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology

D Pastori, VM Cormaci, S Marucci, G Franchino… - International Journal of …, 2023 - mdpi.com
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

Thrombophilia testing and venous thrombosis

JM Connors - New England Journal of Medicine, 2017 - Mass Medical Soc
Thrombophilia Testing and Venous Thrombosis | New England Journal of Medicine Skip to
main content Access provided by Charite - Universitaetsmedizin Berlin The New England …

Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis

SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

S Middeldorp, R Nieuwlaat… - Blood …, 2023 - ashpublications.org
Background Hereditary and acquired thrombophilia are risk factors for venous
thromboembolism (VTE). Whether testing helps guide management decisions is …

Recurrent pregnancy loss: current perspectives

H El Hachem, V Crepaux, P May-Panloup… - … journal of women's …, 2017 - Taylor & Francis
Recurrent pregnancy loss is an important reproductive health issue, affecting 2%–5% of
couples. Common established causes include uterine anomalies, antiphospholipid …

Recurrent implantation failure: A comprehensive summary from etiology to treatment

J Ma, W Gao, D Li - Frontiers in Endocrinology, 2023 - frontiersin.org
Implantation is the first step in human reproduction. Successful implantation depends on the
crosstalk between embryo and endometrium. Recurrent implantation failure (RIF) is a …

[PDF][PDF] Deep vein thrombosis: update on diagnosis and management

PC Kruger, JW Eikelboom, JD Douketis… - Medical Journal of …, 2019 - mja.com.au
Deep vein thrombosis: update on diagnosis and management Page 1 Narrative review MJA 2 10
(11) ▪ 17 June 2 0 19 Deep vein thrombosis: update on diagnosis and management Paul C …

16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends

H Cohen, MJ Cuadrado, D Erkan, A Duarte-Garcia… - Lupus, 2020 - journals.sagepub.com
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …

Perioperative venous thromboembolism prophylaxis

MA Bartlett, KF Mauck, CR Stephenson, R Ganesh… - Mayo Clinic …, 2020 - Elsevier
Venous thromboembolism (VTE) is a preventable cause of postoperative morbidity and
mortality; however, audits suggest that the use of thromboprophylaxis is underused. In this …